You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 13, 2024

ROMAZICON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Romazicon patents expire, and what generic alternatives are available?

Romazicon is a drug marketed by Hoffmann La Roche and is included in one NDA.

The generic ingredient in ROMAZICON is flumazenil. There are four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the flumazenil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Romazicon

A generic version of ROMAZICON was approved as flumazenil by BAXTER HLTHCARE CORP on October 12th, 2004.

  Sign Up

Drug patent expirations by year for ROMAZICON
Recent Clinical Trials for ROMAZICON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sameh Hanna, MDEarly Phase 1
Prisma Health-MidlandsEarly Phase 1
University of California, DavisPhase 4

See all ROMAZICON clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ROMAZICON

US Patents and Regulatory Information for ROMAZICON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche ROMAZICON flumazenil INJECTABLE;INJECTION 020073-001 Dec 20, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROMAZICON flumazenil INJECTABLE;INJECTION 020073-002 Dec 20, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ROMAZICON

See the table below for patents covering ROMAZICON around the world.

Country Patent Number Title Estimated Expiration
Norway 802946 ⤷  Sign Up
Israel 61160 IMIDAZODIAZEPINE DERIVATIVES,THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Sign Up
Finland 803135 ⤷  Sign Up
Finland 73683 ⤷  Sign Up
Japan S5659776 IMIDAZODIAZEPINE DERIVATIVE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.